Nearly half of U.S. coronavirus patients in intensive care are under 65, CDC reports


Older Americans are still at greater risk of death from the new COVID-19 coronavirus, but 38 percent of the U.S. patients known to have been hospitalized for COVID-19 were between age 20 and 54, and nearly half of those admitted to the intensive care unit were adults under 65, the Centers for Disease Control and Prevention reported Wednesday. The report looked at 508 of the first 2,449 coronavirus patients in the U.S. The high rate of hospitalization for younger adults matches the statistics reported from France and Italy.
The report showed that adults of all ages are at risk of getting sick from the coronavirus — of the 2,449 patients examined, 6 percent were 85 and older, 25 percent were 65 to 84, 29 percent were 20 to 44, and 5 percent were 19 and younger, the CDC said. People 20 to 44 — the millennial generation — accounted for 20 percent of those hospitalized and 12 percent of ICU patients.
"I think everyone should be paying attention to this," Columbia University epidemiologist Stephen S. Morse tells The New York Times. "It's not just going to be the elderly. There will be people age 20 and up. They do have to be careful, even if they think that they're young and healthy." And it's not just the health of younger people that has experts worried, adds Dr. Christopher Carlsten, the head of respiratory medicine at the University of British Columbia. "If that many younger people are being hospitalized, that means that there are a lot of young people in the community that are walking around with the infection," putting older and sicker people at risk.
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.

Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
Peter has worked as a news and culture writer and editor at The Week since the site's launch in 2008. He covers politics, world affairs, religion and cultural currents. His journalism career began as a copy editor at a financial newswire and has included editorial positions at The New York Times Magazine, Facts on File, and Oregon State University.
-
Why bosses are hiring etiquette coaches for Gen Z staff
Under The Radar Employers claim young workers are disengaged at interviews and don't know how to behave in the office
-
How will Trump's megabill affect you?
Today's Big Question Republicans have passed the 'big, beautiful bill' through Congress
-
Scientists are the latest 'refugees'
In the spotlight Brain drain to brain gain
-
Kennedy's vaccine panel signals skepticism, change
Speed Read RFK Jr.'s new vaccine advisory board intends to make changes to the decades-old US immunization system
-
Kennedy ousts entire CDC vaccine advisory panel
speed read Health Secretary RFK Jr. is a longtime anti-vaccine activist who has criticized the panel of experts
-
RFK Jr. scraps Covid shots for pregnant women, kids
Speed Read The Health Secretary announced a policy change without informing CDC officials
-
New FDA chiefs limit Covid-19 shots to elderly, sick
speed read The FDA set stricter approval standards for booster shots
-
US overdose deaths plunged 27% last year
speed read Drug overdose still 'remains the leading cause of death for Americans aged 18-44,' said the CDC
-
Trump seeks to cut drug prices via executive order
speed read The president's order tells pharmaceutical companies to lower prescription drug prices, but it will likely be thrown out by the courts
-
RFK Jr.: A new plan for sabotaging vaccines
Feature The Health Secretary announced changes to vaccine testing and asks Americans to 'do your own research'
-
RFK Jr. visits Texas as 2nd child dies from measles
Speed Read An outbreak of the vaccine-preventable disease continues to grow following a decade of no recorded US measles deaths